Clinical Trial Update: The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing ibandronate to zoledronic acid after denosumab discontinuation in postmenopausal osteoporosis and osteopenia, with recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Ibandronate (ibandronate)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Postmenopausal Osteoporosis, Postmenopausal Osteopenia | Phase 4 | Status: NOT_YET_RECRUITING